Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 08-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195 | 496 | 732 | 730 | 852 |
| Receivables | 223 | 28 | 86 | 126 | 51 |
| Inventories | 122 | 218 | 116 | 116 | 116 |
| TOTAL | $714 | $829 | $1,013 | $1,000 | $1,085 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 3 | 3 | 4 |
| Intangibles | 1,696 | 1,440 | 1,380 | 1,348 | 1,241 |
| TOTAL | $1,699 | $1,442 | $1,383 | $1,352 | $1,245 |
| Total Assets | $2,413 | $2,271 | $2,397 | $2,352 | $2,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $1,029 | $812 | $754 | $693 | $424 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 443 | 388 | 337 | 323 | 52 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,029 | $812 | $754 | $693 | $424 |
| Shareholders' Equity | |||||
| Common Shares | 5,140 | 5,140 | 4,832 | 4,832 | 4,832 |
| Retained earnings | -4,132 | -4,052 | -3,713 | -3,783 | -3,495 |
| Other shareholders' equity | 0 | 0 | 87 | 190 | 190 |
| TOTAL | $1,384 | $1,459 | $1,643 | $1,659 | $1,906 |
| Total Liabilities And Equity | $2,413 | $2,271 | $2,397 | $2,352 | $2,330 |